67 related articles for article (PubMed ID: 1767969)
1. [Activated coagulation time during surgery with extracorporeal circulation].
Piatnitskaia GKh; Khodaz MIa; Savina ME; Dement'eva II
Anesteziol Reanimatol; 1991; (5):66-74. PubMed ID: 1767969
[No Abstract] [Full Text] [Related]
2. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
Dercksen SJ; Linssen GH
Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
[TBL] [Abstract][Full Text] [Related]
3. [Activated coagulation time and the concentration of heparin in assessing the level of blood heparinization during operations using artificial blood circulation].
Khodas MIa; Piatnitskaia GKh; Savina ME; Smirnova LA
Anesteziol Reanimatol; 1989; (2):11-5. PubMed ID: 2742179
[TBL] [Abstract][Full Text] [Related]
4. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
[TBL] [Abstract][Full Text] [Related]
5. [New dosage of heparin during cardiac surgery with extracorporeal circulation].
Croston JA
Rev Med Panama; 1991 May; 16(2):127-9. PubMed ID: 1924901
[TBL] [Abstract][Full Text] [Related]
6. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
7. Does preoperative level of antithrombin III predict heparin resistance during extracorporeal circulation?
Rodríguez-López JM; del Barrio E; Lozano FS; Muriel C
Anesth Analg; 2008 Oct; 107(4):1444-5. PubMed ID: 18806070
[No Abstract] [Full Text] [Related]
8. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
Dercksen SJ; Linssen GH
Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
[TBL] [Abstract][Full Text] [Related]
9. Commentary on: The relationship between heparin level and activated clotting time in the adult cardiac surgery population.
Fitzgerald D
Perfusion; 2009 Mar; 24(2):97. PubMed ID: 19654151
[No Abstract] [Full Text] [Related]
10. [Activated coagulation time during extracorporeal circulation: useful for reducing the use of homologous blood?].
Brandi LS; Benedetti M; Russo V; Grana M; Mosca F
Minerva Anestesiol; 1984 Apr; 50(4):127-32. PubMed ID: 6472644
[No Abstract] [Full Text] [Related]
11. Safety issues in heparin and protamine administration for extracorporeal circulation.
Jobes DR
J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
[TBL] [Abstract][Full Text] [Related]
12. A reevaluation of heparin requirements for cardiopulmonary bypass.
Cardoso PF; Yamazaki F; Keshavjee S; Schaefers HJ; Hsieh CM; Wang LS; Glynn MF; Patterson GA; Cooper JD
J Thorac Cardiovasc Surg; 1991 Jan; 101(1):153-60. PubMed ID: 1986159
[TBL] [Abstract][Full Text] [Related]
13. Inaccuracy of coagulation studies performed on blood samples obtained from arterial catheter.
Akinci SB; Salman N; Aykut T; Kanbak M; Aypar U
J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):702-3. PubMed ID: 16202916
[No Abstract] [Full Text] [Related]
14. Clinical heparin coated cardiopulmonary bypass: reduction of systemic heparin requirements for redo cardiac surgery.
Ladowski JS; Schatzlein MH; Peterson AC; Deschner WP; Matheis R; Ellenwood M; Bach J; Moldovan L; McKamey D
ASAIO J; 1996; 42(1):34-6. PubMed ID: 8808455
[TBL] [Abstract][Full Text] [Related]
15. [Heparin management by activated coagulation time during cardiopulmonary bypass].
Shikano K; Shinpo H; Nasu M; Morimoto T; Suzuki T; Yada I; Kusagawa M
Kyobu Geka; 1981; 34(12):934-7. PubMed ID: 7349352
[No Abstract] [Full Text] [Related]
16. [Use of activated coagulation time for controlling the heparinization level during operations with artificial circulation].
Dement'eva II; Savina ME; Piatnitskaia GKh
Anesteziol Reanimatol; 1980 Aug; (4):29-32. PubMed ID: 7416544
[No Abstract] [Full Text] [Related]
17. An unusual cause of a prolonged activated coagulation time during cardiac surgery: congenital hypofibrinogenemia.
Rani TR; Gopinath R
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):725-6. PubMed ID: 18922430
[No Abstract] [Full Text] [Related]
18. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
19. Management of postoperative heparin rebound following cardiopulmonary bypass.
Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
[TBL] [Abstract][Full Text] [Related]
20. [Heparin resistance during cardiopulmonary bypass].
Maeda R; Fukuda H; Nakaigawa Y; Hiruta M; Hirabayashi Y; Seo N
Masui; 2003 Sep; 52(9):1003-5. PubMed ID: 14531265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
